Aortic valve repair versus mechanical valve replacement for root aneurysm: The CAVIAAR Multicentric Study

Despite growing evidence that aortic valve repair improves long-term patient outcomes and quality of life, aortic valves are mostly replaced. We evaluate the effect of aortic valve repair versus replacement in patients with dystrophic aortic root aneurysm up to 4 years. The multicentric CAVIAAR pros...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cardio-thoracic surgery 2022-07, Vol.62 (2)
Hauptverfasser: Lansac, Emmanuel, Di Centa, Isabelle, Danial, Pichoy, Bouchot, Olivier, Arnaud Crozat, Eric, Hacini, Rachid, Doguet, Fabien, Demaria, Roland, Verhoye, Jean Philippe, Jouan, Jerome, Chatel, Didier, Lopez, Stephane, Folliguet, Thierry, Leprince, Pascal, Langanay, Thierry, Latremouille, Christian, Fayad, Georges, Fleury, Jean Philippe, Monin, Jean Luc, Mankoubi, Leila, Noghin, Milena, Berrebi, Alain, Pousset, Sarah, Laubriet-Jazayeri, Aline, Lafourcade, Alexandre, Marcault, Estelle, Kindo, Michel, Payot, Laurent, Bergoend, Eric, Jourdain Hoffart, Cecile, Debauchez, Mathieu, Tubach, Florence
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Despite growing evidence that aortic valve repair improves long-term patient outcomes and quality of life, aortic valves are mostly replaced. We evaluate the effect of aortic valve repair versus replacement in patients with dystrophic aortic root aneurysm up to 4 years. The multicentric CAVIAAR prospective cohort study enrolled 261 patients: 130 underwent standardized aortic valve repair (REPAIR) consisting of remodelling root repair with expansible aortic ring annuloplasty, and 131 received mechanical composite valve and graft replacement (REPLACE). Primary outcome was a composite criterion of mortality, reoperation, thromboembolic or major bleeding events, endocarditis or operating site infections, pacemaker implantation and heart failure, analyzed with propensity score-weighted Cox model analysis. Secondary outcomes included Major Adverse Valve Related Events (MAVRE) and components of primary outcome. Mean age was 56.1 years, valve was bicuspid in 115 patients (44.7%). Up to 4 years, REPAIR did not significantly differ from REPLACE in terms of primary outcome (HR 0.66 [0.39; 1.12]), but showed significantly less valve-related deaths (HR 0.09 [0.02; 0.34]) and major bleeding events (HR 0.37 [0.16; 0.85]) without an increased risk of valve-related reoperation (HR 2.10 [0.64; 6.96]). When accounting for occurrence of multiple events in a single patient, REPAIR group had half the occurrence of MAVRE (RR 0.51 [0.31; 0.86]). Although primary outcome did not significantly differ between REPAIR and REPLACE group, the trend is in favour of REPAIR by a significant reduction of valve-related deaths and major bleeding events. Long-term follow-up beyond 4 years is needed to confirm these findings.
ISSN:1010-7940
1873-734X
DOI:10.1093/ejcts/ezac283